Kaye Biotech Inc. had the following equity account balances at December 31, 2019: 6 $ 42,000 Preferred shares, $2.95, non- cumulative, Authorized: 22,000 shares Issued and outstanding: 6,000 shares Common shares, Authorized: Unlimited Issued and outstanding: 90,000 shares Retained earnings 304,618 44,600 On February 1, 2020, 6,000 preferred shares were issued at $8.70 each. The board of directors declared and paid the annual cash dividend on the preferred shares on June 30, 2020, and a 13% common share dividend was declared and distributed on the same day when the market price per common share was $4.70. On October 1, 2020, 22,000 common shares were issued at $4.84 each. Profit earned during 2020 was $418,800. Required: Using the information provided, prepare the statement of changes in equity for the year ended December 31, 2020. (Amounts to be deducted should be indicated by a minus sign.)